Abstract

FERNANDEZ-MORALES, Donald  and  SAGOT-VERDESIA, Felipe. Uso de la metformina en pacientes con el síndrome del ovario poliquístico . Acta méd. costarric [online]. 2007, vol.49, n.3, pp.140-146. ISSN 0001-6002.

Abstract Metformin has been prescribed for treating type II Diabetes Mellitus of patients with normal renal function. It has also been used with the FDA approval for patients with polycystic ovary syndrome as regulator of the menstrual cycle, and for the treatment of hirsutism and as an ovulation inductor. Since 1980, Burgen et al. pointed the association between hyperandrogenism and hyperinsulinism in patients with polycystic ovary syndrome. The excess of androgens due to the increase of insulin diminish its action.  Metformin mechanism for lowering glucose is a consequence of a decrease in hepatic glucose production and an increase of its utilization. Metformin increases most of insulin biological actions in people with pre-existing insulin resistance and decreases intestinal glucose absorption. In conclusion, metformin is useful for menstrual cycle regulation in comparison with placebo, is not a first choice treatment for hirsutism, and its use as monotherapy for induction of ovulation has not demonstrated a substantial rate improvement in clinical pregnancy. Evidence shows that metformin associated with clomiphene citrate induces ovulation and improves clinical pregnancy rate.

Keywords : Metformina; síndrome del ovario poliquístico; hiperandrogenismo; hiperinsulinemia; resistencia a la insulina; acidosis láctica; oligoamenorreas; hirsutismo; inducción de ovulación; Metformin; polycystic ovary syndrome; hyperandrogenism; hyperinsulinism; insulin resistance; lactic acidosis; oligomenorrhea; hirsutism; ovulation inductor.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )